Current Edition

Daraprim

Martin Shkreli’s former company to pay $40M in settlement over drug price hikes

Shkreli became a symbol of pharmaceutical greed after his company, formerly Turing Pharmaceuticals, bought Daraprim in 2015 and then raised the price to $750 a …

Continue Reading →